Phase II study of Ninjin'yoeito for anorexia in patients with advanced non-small-cell lung cancer
Phase 2
Recruiting
- Conditions
- Advanced non-small-cell lung cancer
- Registration Number
- JPRN-jRCTs041220102
- Lead Sponsor
- aito Tateaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1) Age >= 18-year-old
2) Anorexia (SNAQ score >=14 points)
3) ECOG-PS 0-2
4) Expected survival time>= 12 weeks
5) Written informed consent
6) Advanced non-small-cell lung cancer in stage Ill/IV
7) Meets the following test results
1. Hb >= 8.0 g/dl
2. T-Bil <= 2.0 mg/dl
3. AST, ALT<= 150 IU/L
4. Cre <= 3.0 mg/dl
5. Sp02 >=90% or Pa02 >= 60 Torr
Exclusion Criteria
(1) Receiving cytotoxic chemotherapy within two weeks
(2) Planning to start cytotoxic chemotherapy during the study period
(3) Unable to eat or drink food or take medicines
(4) Treatable causes of anorexia, including electrode abnormalities, peptic ulcer, severe constipation, intracranial disease, psychosis, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method